ABSTRACT INTRODUCTION: Trypanosoma cruzi is the etiologic agent of Chagas disease in humans, mainly in Latin America. Trypanosome stocks were isolated by hemoculture from patients followed at Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ) and studied using different approaches. METH...
Abstract Benznidazole, drug of choice for Chagas disease (CD), has been associated with a high incidence of adverse reactions that can become serious, necessitating discontinuation of the drug. We describe the case of a Bolivian patient living in Spain for 9 years, who, following treatment with benznidaz...
ABSTRACT INTRODUCTION: Chagas disease (CD) is currently considered a neglected disease; hence, identifying the factors associated with its high prevalence is essential. This study aimed to identify the seroprevalence of and the possible factors associated with CD in inhabitants of the City of Limoeiro ...
Anticuerpos Antiprotozoarios/sangre,
Brasil/epidemiologÃa,
Enfermedad de Chagas/diagnóstico,
Enfermedad de Chagas/epidemiologÃa,
Enfermedades Endémicas,
Ensayo de Inmunoadsorción Enzimática,
Métodos Epidemiológicos,
Técnica del Anticuerpo Fluorescente Indirecta,
Persona de Mediana Edad,
Factores Socioeconómicos,
Trypanosoma cruzi/inmunologÃa
Abstract: INTRODUCTION: Panstrongylus herreri is a main Chagas disease vector, and its success as a vector stems from its ability to establish domiciliated colonies; we aimed to explore its biology and reproduction. METHODS: The average amount of blood ingested and the time from the beginning of a blo...
Luna, Expedito JA;
Furucho, Celia R;
Silva, Rubens A;
Wanderley, Dalva M;
Carvalho, Noemia B;
Satolo, Camila G;
Leite, Ruth M;
Silveira, Cassio;
Silva, Lia MB;
Aith, Fernando M;
Carneiro Jr, Nivaldo;
Shikanai-Yasuda, Maria A.
With the urbanisation of the population in developing countries and the process of globalisation, Chagas has become an emerging disease in the urban areas of endemic and non-endemic countries. In 2006, it was estimated that the prevalence of Chagas disease among the general Bolivian population was 6.8%. ...
Anticuerpos AntihelmÃnticos/sangre,
Bolivia/etnologÃa,
Brasil/epidemiologÃa,
Enfermedad de Chagas/diagnóstico,
Enfermedad de Chagas/epidemiologÃa,
Emigrantes e Inmigrantes/estadÃstica & datos numéricos,
Ensayo de Inmunoadsorción Enzimática,
Prevalencia,
Factores de Riesgo,
Estudios Seroepidemiológicos,
Trypanosoma cruzi/inmunologÃa
Repensando novas estratégias e paradigmas voltados para as práticas de saúde que o SUS (Sistema Único de Saúde) oferece aos brasileiros, é de suma importância a inserção da promoção a saúde com educação permanente aos profissionais e a população no que diz respeita ao vetor transmissor da...
A doença de Chagas, causada pelo parasita protozoário Trypanosoma cruzi, afeta milhões de pessoas, a maioria delas vivendo na América latina. Apesar dos avanços da medicina e da biotecnologia, ainda existem poucas opções de tratamento para indivÃduos com a doença. Assim, é importante compreende...
Introduction: Blood donation should be voluntary, anonymous and altruistic, and the donor should not, directly or indirectly, receive any remuneration or benefit by virtue of donating blood. Like any other therapeutic method, transfusion procedures are not risk free and can expose the patient to a severa...
A tripanossomÃase americana, mais conhecida como Doença de Chagas (DC), tem por agente causal o Trypanosoma cruzi (T. cruzi). Para efeitos práticos, o tratamento da DC pressupõe uma terapêutica especÃfica e sintomática, embora haja divergências quanto à s porcentagens de cura no tratamento etiolÃ...
Abstract: Residual insecticide spraying still is the main tool used to suppress house infestations with Chagas disease vectors. While manual compression sprayers (MCS) have traditionally been used in Latin America, Mendoza's vector control program from Argentina introduced the use of a modified motorized...
